$DGWR Overview - Completely Revised - April 28,

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
480
$DGWR Overview - Completely Revised - April 28, 2024

Business Sector

- A waste, recycling and remediation services company for commercial customers.

Key Points - 2023 Record Annual Earnings PR - April 24, 2024

- 2023 Revenue 2.5 x 2022 Revenue - up 155%.

- 2023 $2,682,762 vs 2022 $1,053,612.

- 2023 record annual revenue driven by strong organic growth and strategic acquisitions.

- Gross Profit margins continue to improve - 2023 76% vs 2022 62%.

- This highlights the company's operational efficiency and pricing power.

- Operating Loss down substantially:

-- 2023 $259,314 vs 2022 $784,238 as the company benefited from economies of scale.

- On a GAAP basis, Net Loss improved:

-- 2023 $690,140 vs 2022 $1,194,221.

-- Notably, the 2023 Net Loss included $101,993 of non-cash derivative liability expenses.

-- Excluding this item, Adjusted Net Loss $588,147 - 51% improvement.

- During the year, Deep Green's wholly owned subsidiary Lyell Environmental Services completed a large asbestos removal project at Vanderbilt University Medical Center.

- The contract win demonstrated Deep Green's expertise and ability to flawlessly execute large-scale, complex jobs while winning the confidence of respected institutions such as Vanderbilt University Medical Center.

- The ability to complete $M+ projects on time and to the satisfaction of the institutional customers is beginning to generate interest from other large commercial players such as Vanderbilt for the benefit of Deep Green.

- Building on this success, management intends to accelerate geographic expansion into attractive metro markets across Tennessee, Alabama and Georgia while adding complementary remediation services to drive growth.

- Deep Green is actively evaluating strategic acquisition opportunities to further penetrate the fragmented $109 Billion environmental services market.

- CEO's comments:

-- "I am extremely proud of our team's unwavering commitment to executing our growth strategy which has propelled Deep Green to new heights in 2023".

-- "Achieving over $2.6 Million in annual revenue with industry-leading gross margins demonstrates the immense earnings potential of our streamlined, high-quality operations".

- President's comments:

-- "2023 was a transformational year for Deep Green as we built a highly profitable foundation capable of sustaining rapid growth".

-- "Our robust pipeline of organic growth opportunities, accretive M&A targets, and new service verticals provides a clear roadmap to accelerate expansion in the $109 billion environmental remediation market, which is projected to reach $163 billion by 2027".

Additional Key Points - Shareholder Update PR - April 2, 2024 - Not Covered / Superseded By Record Annual Earnings PR

- Successful completion of $2 Million asbestos removal project at Vanderbilt University Medical Center in Nashville by subsidiary Lyell Environmental Services, Inc:

-- Represented the largest single abatement project in the history of Deep Green.

-- Also demonstrated Deep Green's commitment to environmental stewardship and positioned the company for accelerated growth.

- Completed the sale of wholly-owned subsidiary DG Research Inc - Amwaste to Amwaste of Georgia, LLC for a purchase price of $175,000.

-- This divestiture aligns with ongoing efforts to optimize operations and concentrate on core competencies in environmental safety, analysis, testing, remediation, and abatement services.

-- It also significantly enhances the cash position which will allow the company to capitalize on its hybrid strategy of organic growth and growth through synergistic acquisitions.

- Uplisted to OTCQB wef January 22, 2024. This milestone will offer the company broader acceptance within the investment banking community and help it continue to raise the capital needed to achieve its acquisition goals.

- CEO comments:

-- "Looking ahead, I want to emphasize that Deep Green is dedicated to pursuing strategic opportunities to broaden its portfolio of environmental services and expand nationally."

-- "As a leading, vertically integrated waste management and remediation provider, we are well-positioned to capitalize on the growing demand for eco-friendly and compliant solutions to pressing environmental challenges faced by our customers."

-- "Investors should anticipate Deep Green pursuing additional acquisitions and adding new remediation services to complement its existing capabilities in the environmental remediation services markets, including the removal of toxic materials, such as mold, lead, radon, and asbestos, across both commercial and residential markets."

-- "We remain committed to creating additional value for our shareholders as we work toward our ambition of being the recognized national leader in the waste, recycling, and remediation services industry."

PRs - 2024

Ongoing PR campaign with 6 x releases so far in 2024.

News - January 4. Deep Green Waste & Recycling Reports Record Third Quarter Earnings.

News - January 18. Deep Green Waste & Recycling, Inc. [DGWR] Announces Up-Listing to OTCQB Venture Market.

News - February 13. Deep Green Completes $2M Asbestos Removal Project at Vanderbilt University Medical Center in Nashville - Completed Project Represents the Largest Single Abatement Project in the History of Deep Green.

News - March 25. Deep Green Completes Asset Sale of Georgia Subsidiary and Strengthens Company Cash Position.

News - April 2. Deep Green Waste & Recycling Shareholder Letter Highlights Exceptional Year.

News - April 24. Deep Green Waste & Recycling Reports Record Annual Earnings - Revenues Increase 2.5x from 2022, growing by 155 Percent and Gross Profit Margins Continue to Improve.

Current Tier - OTCQB

Share Structure - Updated April 27, 2024

Transfer Agent Verified

No change - no dilution


Authorized Shares: 3,000,000,000

Outstanding Shares: 8,814,613

- Restricted: 4,485,540

- Unrestricted: 4,329,073

Note: Pre-warned 1:1500 reverse split completed June 20, 2023 as planned - to attract investment with higher price in $0.1 > $1+ range.

Trading Pre-Planned Reverse Split

2022

.0042 > .0060 on April 12 - 43%

.0024 > .0039 on May 19 - 62.5%

.0025 (previous close) > .0036 on June 23 - 44%

.0022 > .0029 on July 7 - 32%

.0008 (previous close) > .0013 on October 10 - 62.5%

.0009 > .0013 on October 12 - 44.4%

.0007 > .0009 on October 18 - 28.5%

.0005 > .0008 on November 17 - 60%

.0008 > .0011 on November 21 - 37.5%

.0004 > .0005 on November 30 - 25%

Trading Post Planned Reverse Split June 20, 2023 Onwards

R/s was 1:1500

Cheapest shares available in quantity pre-r/s were .0002 - par post r/s .3000

Hod June 20, 2023 for new buys on ask .5000

There is a large spread between the bid and the ask with almost no chance of getting a bid fill due to a few savvy traders continually outbidding each other.

Whenever there is a walked down ask it is usually taken out completely by those looking to create an inventory for future runs in the long-term.

Websites / Social Media

$DGWR Website: https://deepgreenwaste.com/

$DGWR Twitter: https://twitter.com/DeepGreenDGWR

$DGWR Facebook: https://www.facebook.com/deepgreenwaste/

Lyell Website: https://www.lyellenvironmentalservices.com/

Not a financial advisor - just stating what I'm basing my trading decisions on.

I will be holding some $DGWR in my portfolio throughout 2024 and into 2025 for long-term growth, trading some on surges from the bottom up too and reloading on any dips.




Deep Green Waste & Recycling, Inc. (DGWR) Stock Research Links

DGWR Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Veterinary Biologics Growth Has a Valuable Catch Ahead

Updated Category News Views 94

Pet allergies and livestock disease are hardly glamorous, yet they are becoming a durable spending lane. The veterinary biologics market is projected to rise from $2.85 billion in 2026 to $3.69 billion by 2031, a 5.3% compound annual growth rate. That is not the kind of growth figure that makes anyone pound the table, and frankly it should not. It is the sort that can...

Continue Reading
Oman’s Dhofar II Wind Deal Clears Financing Hurdle

Updated Category News Views 111

Dhofar’s next wind farm has crossed the line that matters: financial close. That is less glamorous than turbines spinning against an Omani skyline, but it is the point where a project stops being an attractive deck and becomes a real contractual obligation. Sembcorp Utilities, alongside OQ Alternative Energy through Naseem Dhofar SAOC, has brought the 125-megawatt...

Continue Reading
Trip.Best Expands Global Travel Discovery Footprint

Updated Category News Views 123

Sydney just became the map pin for a fairly serious travel-content land grab. Trip.Best, Trip.com Group's ranking brand, has rolled out its 2027 Annual Rankings with coverage of all seven continents for the first time. This is not an earnings release, and nobody should pretend a hotel list magically turns into revenue by lunchtime. Still, the jump from 85 to 98 annual...

Continue Reading
Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 105

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading
North Richland Hills Bets on Its Visitor Momentum Now

Updated Category News Views 65

A crowded family attraction map is a nice problem for a Texas city to have, and North Richland Hills is trying to turn that pile of assets into a cleaner regional tourism machine. On Nov. 20, 2026, the city introduced “The Place You Never Outgrow,” its first destination-marketing campaign, built with Flat Five Marketing. This is not a stock story in the usual...

Continue Reading
Surgery Partners Deal Faces Fresh Price Scrutiny Ahead

Updated Category News Views 66

A $23.50 cash offer can look wonderfully tidy until somebody asks how the number was built. That is where Surgery Partners shareholders find themselves after Halper Sadeh LLC said it is investigating the proposed sale of Surgery Partners, Inc. to HealthSpan Partners. The firm is examining whether the company’s board obtained a fair price, ran a conflict-free process,...

Continue Reading
Franklin County Trees Raise Funds and Honor Veterans

Updated Category News Views 23

Holiday charity works best when it gives people something tangible to gather around, and Franklin County has found a pretty sturdy version of that formula. Its eighth annual Festival of Trees opens at 4 p.m. Saturday, November 21, at the Franklin County 11/30 Visitors Center in downtown Chambersburg, carrying the theme A Salute To Veterans. More than 80 decorated trees...

Continue Reading
Bybit Adds ANT, but Trading Access Has Real Fine Print

Updated Category News Views 50

Anthropic shares have landed on Bybit Stocks, and the headline is simple enough: eligible customers can trade ANT after the company’s public listing. But this is one of those announcements where the plumbing deserves as much attention as the shiny new ticker. A platform can make access feel effortless right up until a jurisdiction rule, a verification hurdle, or a...

Continue Reading
Neurelis Founder Earns EY's 2026 Top Entrepreneur Honor

Updated Category News Views 65

Some business awards are wallpaper; this one carries real clinical weight. EY US named Craig Chambliss, CEO and co-founder of Neurelis, its Entrepreneur Of The Year 2026 National Overall Award winner. In a sector where plenty of companies talk grandly about changing lives and then vanish into the regulatory fog, the underlying story matters more than the trophy. Neurelis...

Continue Reading
Workers Are Burning Savings as Pay Falls Behind Costs

Updated Category News Views 47

Payroll optimism has been ground into dust by the ordinary bills nobody can dodge. Monster's 2026 Cost of Living Report says 93% of employed U.S. workers feel their wages are failing to keep up with costs, barely different from 95% in both 2024 and 2025. That is not a blip, and it is not workers merely grousing about prices. Three years of nearly identical frustration...

Continue Reading

Top 5 Most Recently Viewed Articles

Deere & Co's Future Amid Repair Debates and Financial Insights

Updated Category News Views 81

Barclays Reconfirms Target for Deere & Co Barclays recently reaffirmed its Overweight rating on Deere & Co (NYSE: DE) and maintained a $400 price target, amidst an ongoing dialogue surrounding the right to repair. This discussion has re-emerged in the spotlight, temporarily impacting Deere's share price before it regained ground. The analyst noted that this issue has been...

Continue Reading
Inventor Offers Hospital Sign to Prevent Infections

Updated Category News Views 38

A Fresh Take on Infection Control Some days you stumble across an idea that just clicks—like the latest gadget for hospitals. Forget complex systems or high-tech cameras; this is about a simple sign that screams 'stop!' before you walk into trouble. It’s designed to safeguard hospital staff by alerting them to take precautions before entering rooms with infectious...

Continue Reading
JPMorgan Adjusts NOV Stock Outlook Amidst Market Challenges

Updated Category News Views 64

JPMorgan Adjusts NOV Stock Outlook Recently, JPMorgan made changes to its financial outlook for NOV Inc. (NYSE: NOV), a key player in the energy equipment and services sector. The investment firm lowered its price target from $23 to $22 but maintained an Overweight rating on the stock. This adjustment was driven by expectations of a slowdown in North American operations...

Continue Reading
Madrigal Pharmaceuticals Expands Workforce with Incentive Awards

Updated Category News Views 234

Madrigal Pharmaceuticals Strengthens Workforce with New Grants Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a leading biopharmaceutical company dedicated to innovative treatments for metabolic dysfunction-associated steatohepatitis (MASH), has recently taken a significant step to bolster its team. The company announced granting equity inducement awards to 76 new...

Continue Reading
Pomerantz Investigates Investor Claims Against Abacus Global Management

Updated Category News Views 272

Pomerantz Law Firm's Investigation into Abacus Global Management In recent news, the Pomerantz Law Firm has embarked on an investigation regarding Abacus Global Management, Inc. (NASDAQ: ABL). This investigation revolves around potential securities fraud and other unlawful business practices committed by the company and some of its executive members. For investors...

Continue Reading